Lyme Disease Test Granted FDA Breakthrough Device Designation
The test detects Borrelia bacteria directly from skin samples at tick bite sites.
The test detects Borrelia bacteria directly from skin samples at tick bite sites.
The collaboration aims to create a non-invasive diagnostic for Pseudomonas aeruginosa using miniaturized gas chromatography-mass spectrometry technology.
The droplet digital PCR assay shows 90.9% sensitivity and can detect previously missed cases of the bacterial infection.
A field-deployable test demonstrates high sensitivity in identifying low-level infections that traditional methods miss, potentially supporting elimination efforts.
Molecular sensor releases thyme flavor when encountering influenza virus, potentially enabling at-home screening through gum or lozenges.
New assays detect common bacterial causes of infectious gastroenteritis using molecular technology on existing diagnostic platforms.
The test uses Abbott's simpli-COLLECT platform to detect chlamydia, gonorrhea, trichomonas, and mycoplasma genitalium from patient-collected specimens.